Former FDA Counsel Philip Desjardins Quoted in MedTech Dive on FDA Layoffs and Device Safety Communications
Philip Desjardins, Life Sciences & Healthcare Regulatory partner and former official with the FDA’s Center for Devices and Radiological Health (CDRH), was recently quoted in the MedTech Dive article, “RFK’s FDA layoffs could slow safety communications, experts warn.” The story explores how recent staffing cuts at the FDA, particularly in CDRH, may delay public notices related to medical device recalls and safety alerts.
Desjardins said, “I worry critical information could be delayed in being communicated to patients and other stakeholders,” noting that responsibility for these communications may fall to device review teams already managing heavy workloads. He cautioned that this shift could strain resources and delay other agency priorities, such as product submissions and post-market reviews.
